Trehalose, a type of carbohydrate (sugar), could hold the key to a new treatment for diabetes and other metabolic diseases, but it might also fuel more severe Clostridium difficile (C. difficile) infections.
By John Shultz Randy Rasmussen, CEO of BioFire Diagnostics, delivered the keynote speech at the 2018 bioMérieux “Night at the Museum” event held in Salt Lake City, Utah on July 9th, 2018. In his talk, Randy relates the challenges he has faced in his own career in the fight against infectious disease, while reflecting on …
If geography truly is destiny, this saying was never more true than during the influenza pandemic of 1918. Where you lived often determined if you survived, with high fatality rates in large cities, overcrowded military bases, and the congested refugee camps that housed the displaced during World War 1.
One hundred years ago this year, an influenza pandemic spread around the globe at an alarming rate. When the influenza season ended in 1919, one out of every three human beings, or about 600 million people, suffered from the infection, called the Spanish flu, and at least 50 million people did not survive it.
Never Miss a Post!
- Acute and Intensive Care
- Antibiotic Resistance
- Antimicrobial Resistance
- Antimicrobial Stewardship
- Book Reviews
- Carbapenem-Resistant Enterobacteriaceae (CRE)
- Case Studies
- Clostridium difficile (C. difficile)
- Compliance Standards
- Cystic Fibrosis
- Drugs and Drug Efficacy